Binding of glucocorticosteroids to hepatic erythropoietic cells of the rat fetus.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 7241018)

Published in J Endocrinol on May 01, 1981

Authors

C Billat, J M Felix, P Mayeux, R Jacquot

Articles citing this

In vitro effect of dexamethasone phosphate on hematopoietic progenitor cells in preterm infants. Arch Dis Child Fetal Neonatal Ed (1998) 0.75

Articles by these authors

Autoantibodies against erythropoietin in a patient with pure red-cell aplasia. N Engl J Med (1996) 2.38

Hypoglycaemia in paediatric admissions in Mozambique. Lancet (1994) 2.23

A critical role for phosphoinositide 3-kinase upstream of Gab1 and SHP2 in the activation of ras and mitogen-activated protein kinases by epidermal growth factor. J Biol Chem (2000) 1.56

PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML. Leukemia (2008) 1.55

Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells. Blood (2000) 1.52

Identification of tyrosine residues within the intracellular domain of the erythropoietin receptor crucial for STAT5 activation. EMBO J (1996) 1.49

Mutation in RAP1 is a rare event in myelodysplastic syndromes. Leukemia (2005) 1.44

[Antibodies against human recombinant erythropoietin: an unusual cause of erythropoietin resistance]. Nephrologie (2002) 1.41

Proteasomes regulate erythropoietin receptor and signal transducer and activator of transcription 5 (STAT5) activation. Possible involvement of the ubiquitinated Cis protein. J Biol Chem (1998) 1.39

The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor activity in acute myeloid leukemia. Leukemia (2011) 1.37

A sequence of the CIS gene promoter interacts preferentially with two associated STAT5A dimers: a distinct biochemical difference between STAT5A and STAT5B. Mol Cell Biol (1998) 1.32

Perspectives on inhibiting mTOR as a future treatment strategy for hematological malignancies. Leukemia (2010) 1.32

Identification of JAK protein tyrosine kinases as signaling molecules for prolactin. Functional analysis of prolactin receptor and prolactin-erythropoietin receptor chimera expressed in lymphoid cells. EMBO J (1994) 1.30

Biology of erythropoietin. Haematologica (1998) 1.26

The molecular biology of erythropoietin. Nephrol Dial Transplant (1999) 1.23

Development of glycogen storage ability under cortisol control in primary cultures of rat fetal hepatocytes. Dev Biol (1973) 1.17

Purification, amplification and characterization of a population of human erythroid progenitors. Br J Haematol (1999) 1.15

Multimeric structure of the membrane erythropoietin receptor of murine erythroleukemia cells (Friend cells). Cross-linking of erythropoietin with the spleen focus-forming virus envelope protein. J Biol Chem (1991) 1.12

Plasma glucose, progesterone and immunoreactive insulin levels in the lactating rat. Horm Metab Res (1974) 1.11

Erythropoietin induces the tyrosine phosphorylation of GAB1 and its association with SHC, SHP2, SHIP, and phosphatidylinositol 3-kinase. Blood (1999) 1.11

Erythropoietin induces the tyrosine phosphorylation of its own receptor in human erythropoietin-responsive cells. J Biol Chem (1992) 1.11

Fly-pollinated Pleurothallis (Orchidaceae) species have high genetic variability: evidence from isozyme markers. Am J Bot (2001) 1.04

The erythropoietin receptor of rat erythroid progenitor lens. Characterization and affinity cross-linkage. J Biol Chem (1987) 1.02

A phase Ib GOELAMS study of the mTOR inhibitor RAD001 in association with chemotherapy for AML patients in first relapse. Leukemia (2013) 1.01

Proteasomes regulate the duration of erythropoietin receptor activation by controlling down-regulation of cell surface receptors. J Biol Chem (2000) 0.99

Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation. EMBO J (1996) 0.98

Bcl-2 targeted overexpression into the erythroid lineage of transgenic mice delays but does not prevent the apoptosis of erythropoietin-deprived erythroid progenitors. Blood (1997) 0.98

Identification of genes preferentially expressed in the pathogenic yeast phase of Paracoccidioides brasiliensis, using suppression subtraction hybridization and differential macroarray analysis. Mol Genet Genomics (2004) 0.96

Missense mutation of the erythropoietin receptor is a rare event in human erythroid malignancies. Blood (1996) 0.96

[Blood insulin in the maternal and fetal rat]. Horm Metab Res (1969) 0.96

[Study of the composition and nutritive value of corn opaque 2 and sunflower meal]. Ann Nutr Aliment (1970) 0.95

Effectiveness of a vaccine composed of heat-killed Candida albicans and a novel mucosal adjuvant, LT(R192G), against systemic candidiasis. Infect Immun (1999) 0.94

Erythropoietin induces the tyrosine phosphorylation of insulin receptor substrate-2. An alternate pathway for erythropoietin-induced phosphatidylinositol 3-kinase activation. J Biol Chem (1997) 0.92

KU 812: a pluripotent human cell line with spontaneous erythroid terminal maturation. Blood (1989) 0.91

Role of Gab proteins in phosphatidylinositol 3-kinase activation by thrombopoietin (Tpo). Oncogene (2001) 0.90

Cooperation between STAT5 and phosphatidylinositol 3-kinase in the IL-3-dependent survival of a bone marrow derived cell line. Oncogene (2000) 0.90

Granulocyte-macrophage colony-stimulating factor and erythropoietin act competitively to induce two different programs of differentiation in the human pluripotent cell line UT-7. Blood (1992) 0.88

Constitutive phosphoinositide 3-kinase activation in acute myeloid leukemia is not due to p110delta mutations. Leukemia (2006) 0.88

Erythropoietin induction of tissue inhibitors of metalloproteinase-1 expression and secretion is mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways. Cell Growth Differ (2000) 0.87

Circulating insulin and tissular reactivity to insulin in the rat during the perinatal period. Horm Metab Res (1971) 0.86

Fas expression at diagnosis as a biomarker of azacitidine activity in high-risk MDS and secondary AML. Leukemia (2012) 0.85

Expression of the oxytocin and vasopressin genes in the rat hypothalamus during development: an in situ hybridization study. Brain Res Dev Brain Res (1989) 0.85

Murine erythroleukaemia cells (Friend cells) possess high-affinity binding sites for erythropoietin. FEBS Lett (1987) 0.84

Tyrosine phosphorylation of the erythropoietin receptor: role for differentiation and mitogenic signal transduction. Blood (1995) 0.83

The large neurofilament subunit (NF-H) of the rat: cDNA cloning and in situ detection. Biochem Biophys Res Commun (1988) 0.83

The signal transduction pathway of erythropoietin involves three forms of mitogen-activated protein (MAP) kinase in UT7 erythroleukemia cells. Eur J Biochem (1995) 0.82

Autocrine stimulation by erythropoietin (Epo) requires Epo secretion. Blood (1994) 0.82

Alterations of the phosphoinositide 3-kinase and mitogen-activated protein kinase signaling pathways in the erythropoietin-independent Spi-1/PU.1 transgenic proerythroblasts. Blood (2001) 0.81

Inhibition of the erythropoietin-induced erythroid differentiation by granulocyte-macrophage colony-stimulating factor in the human UT-7 cell line is not due to a negative regulation of the erythropoietin receptor. Blood (1996) 0.81

Erythropoietin synthesis by tumor cells in a case of meningioma associated with erythrocytosis. Blood (1993) 0.81

Spontaneous and Fas-induced apoptosis of low-grade MDS erythroid precursors involves the endoplasmic reticulum. Leukemia (2008) 0.81

Physical and functional interaction between p72(syk) and erythropoietin receptor. J Biol Chem (1998) 0.81

Spleen focus-forming virus long terminal repeat insertional activation of the murine erythropoietin receptor gene in the T3Cl-2 friend leukemia cell line. J Biol Chem (1991) 0.81

Downregulation of interleukin-12 (IL-12) responsiveness in human T cells by transforming growth factor-beta: relationship with IL-12 signaling. Blood (1999) 0.81

Preparation and biological properties of monoclonal antibodies against human erythropoietin. Hybridoma (1993) 0.80

[Effect of hydrocortisone and adrenalectomy on sucrase activity of rat intestine during weaning]. C R Acad Sci Hebd Seances Acad Sci D (1970) 0.80

Serum progesterone and immuno-reactive insulin levels in the pregnant rat. Horm Metab Res (1973) 0.80

Involvement of the p38 mitogen-activated protein kinase pathway in tissue inhibitor of metalloproteinases-1-induced erythroid differentiation. FEBS Lett (2000) 0.80

Activation of Raf-1 and mitogen-activated protein kinases by erythropoietin and inositolphosphate-glycan in normal erythroid progenitor cells: involvement of protein kinase C. Cell Signal (1997) 0.80

In vitro and in vivo regulation of hepatic erythropoiesis by erythropoietin and glucocorticoids in the rat fetus. Exp Hematol (1982) 0.80

Coupling of heterotrimeric Gi proteins to the erythropoietin receptor. J Biol Chem (2000) 0.80

Nucleophosmin status may influence the therapeutic decision in de novo acute myeloid leukemia with normal karyotype. Leukemia (2006) 0.80

Expression of the c-ets1 gene in the hypothalamus and pituitary during rat development. Brain Res Dev Brain Res (1996) 0.79

Glucocorticoids and evolution of haemopoietic tissue in the liver of the rat foetus. Ann Immunol (Paris) (1977) 0.79

Tyrosine residues of the erythropoietin receptor are dispensable for erythroid differentiation of human CD34+ progenitors. Biochem Biophys Res Commun (1999) 0.79

[Research on the functional differentiation of the liver in the rat fetus. UDPG-transglucosylase activity and glycogen content after hydrocortisone administration]. C R Acad Sci Hebd Seances Acad Sci D (1967) 0.79

Studies on the different forms of material reacting with antiinsulin antibodies in the fetal and adult rat. Horm Metab Res (1975) 0.79

Ineffective erythropoiesis in myelodysplastic syndromes: correlation with Fas expression but not with lack of erythropoietin receptor signal transduction. Br J Haematol (1999) 0.79

BCR-ABL and constitutively active erythropoietin receptor (cEpoR) activate distinct mechanisms for growth factor-independence and inhibition of apoptosis in Ba/F3 cell line. Oncogene (1998) 0.78

Abnormal erythropoietin (Epo) gene expression in the murine erythroleukemia IW32 cells results from a rearrangement between the G-protein beta2 subunit gene and the Epo gene. Oncogene (1997) 0.78

Ectopic expression of the erythropoietin receptor in a murine interleukin-6-dependent plasmacytoma cell line (TEPC-2027) confers proliferative responsiveness to erythropoietin. Blood (1997) 0.78

[Hematopoietic tissue in the fetal liver of the rat at the end of gestation. 3. Effects of fetal hypophysectomy]. Arch Anat Microsc Morphol Exp (1969) 0.78

Putative oncogenic role of the erythropoietin receptor in murine and human erythroleukemia cells. Blood (1994) 0.78

In situ localization of NF-H neurofilament subunit mRNAs in rat brain. Dev Neurosci (1991) 0.77

Erythropoietin (Epo) receptor and Epo mimetics. Adv Nephrol Necker Hosp (1999) 0.77

A translocated erythropoietin receptor gene in a human erythroleukemia cell line (TF-1) expresses an abnormal transcript and a truncated protein. Blood (1995) 0.77

[Overview of erythropoietin]. Nephrologie (1991) 0.77

[Study with electron microscope of rat fetal hepatocytes in primary culture: action of cortisol]. C R Acad Sci Hebd Seances Acad Sci D (1972) 0.77

Evidence for glucocorticosteroid receptors in the erythroid cell line of fetal rat liver. J Endocrinol (1983) 0.77

Erythropoietin induces glycosylphosphatidylinositol hydrolysis. Possible involvement of phospholipase c-gamma(2). J Biol Chem (1999) 0.77

Induction of erythropoietin receptors during aclacinomycin-mediated erythroid differentiation of K562 leukemia cells. Leukemia (1991) 0.77

Ontogeny of proenkephalin gene expression in the rat hypothalamus. Brain Res Dev Brain Res (1991) 0.76

Expression of functional beta-platelet-derived growth factor receptors on hematopoietic cell lines. Cytokine (1993) 0.76

Effect of the antiglucocorticoid agent RU 38486 on the dexamethasone inhibition of Friend cell differentiation. Biochim Biophys Acta (1985) 0.76